PHARMACOLOGICAL CARDIAC PROTECTION: WHAT IS NEW?
The lecture is devoted to the current state of pharmacological cardiac protection in patients with a high cardiac risk undergoing non-cardiac and cardiac surgery with cardiopulmonary bypass. It describes the main etiopathogenetic mechanisms of ischemic reperfusion myocardial damage. The possible car...
Main Author: | I. A. Kozlov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
NEW TERRA Publishing House
2019-05-01
|
Series: | Вестник анестезиологии и реаниматологии |
Subjects: | |
Online Access: | https://www.vair-journal.com/jour/article/view/321 |
Similar Items
-
Effect of the Aortic Root Infusion of Sufentanil on Ischemia-Reperfusion Injury in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Clinical Trial
by: Mohammad Bagher Khosravi, et al.
Published: (2019-10-01) -
Anesthetic management of antiphospholipid syndrome patients who underwent cardiac surgery: three cases report
by: Hyunwook Cho, et al.
Published: (2014-02-01) -
Effect of cardiopulmonary bypass on hemostasis in patients undergoing cardiac surgery
by: Jubayer Ahmad, et al.
Published: (2018-05-01) -
Remimazolam anesthesia for cardiac surgery with cardiopulmonary bypass: a case report
by: Kota Saito, et al.
Published: (2021-03-01) -
Comportamiento de los pacientesancianosoperados de cirugíacardíaca con circulaciónextracorpórea/ Evolution of elderly patients who underwent cardiac surgery with cardiopulmonary bypass
by: Alain Moré Duarte, et al.
Published: (2015-10-01)